Abstract:Breast cancer is the second most prevalent cancer in women worldwide. Long non‑coding RNAs (lncRNAs) have been identified as important regulators of tumorigenesis and tumor metastasis. lncRNA FGD5‑AS1 has been previously reported as a carcinogenic gene, however its role in breast cancer has yet to be investigated. The present study aimed to understand the function of lncRNA FGD5‑AS1 in breast cancer and examine the underlying molecular mechanisms. Sample tissues for downstream gene expression profiling were collected from patients with breast cancer (n=23). The effect of FGD5‑AS1 overexpression on cell viability, invasion and migration has been studied in breast cancer cells (MDA‑MB‑231). Changes in glycolysis were monitored by comparing glucose consumption, lactate production and ATP levels. Using StarBase and TargetScan databases a putative interaction between FGD5‑AS1, miR‑195‑5p and SNF1‑like kinase 2 (NUAK2) was predicted <i>in silico</i>. Expression levels of FGD5‑AS1, has‑miR‑195‑5p and NUAK2 were validated by reverse transcription‑quantitative PCR and interactions were validated using dual‑luciferase reporter assays and RNA pull‑down. High expression of lncRNA FGD5‑AS1 was detected in breast cancer tissue samples and disease model cell lines. Silencing of FGD5‑AS1 led to decreased cell proliferation, migration and invasion. It was identified that at a molecular level FGD5‑AS1 serves as a sponge of miR‑195‑5p and alters the expression of its downstream target gene NUAK2. In breast cancer lncRNA FGD5‑AS1 serve a key role in glycolysis and tumor progression via the miR‑195‑5p/NUAK2 axis. The findings of the present study indicated FGD5‑AS1 as a candidate target for intervention in patients with breast cancer.

Long Noncoding RNA GAS6-AS2 Sponges Microrna-493, Thereby Enhancing the Malignant Characteristics of Breast Cancer Cells Via Upregulation of FUT4.

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

RETRACTED ARTICLE: Long Non-Coding RNA GAS6-AS1 Acts As a Cerna for Microrna-585, Thereby Increasing EIF5A2 Expression and Facilitating Hepatocellular Carcinoma Oncogenicity

GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner

Increased Expression of Long Noncoding RNA GAS6-AS2 Promotes Proliferation and Inhibits Apoptosis of Melanoma Cells Via Upregulating GAS6 Expression.

Lncrna CERS6-AS1 As Cerna Promote Cell Proliferation of Breast Cancer by Sponging Mir-125A-5p to Upregulate BAP1 Expression.

Long Noncoding RNA DLX6-AS1 Promotes Breast Cancer Progression Via Mir-505-3p/runx2 Axis.

Promising Long Noncoding RNA DLX6-AS1 in Malignant Tumors

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Long Noncoding RNA DLX6-AS1 Promotes Cell Growth and Invasiveness in Bladder Cancer Via Modulating the Mir-223-hsp90b1 Axis

LncRNA GAS5 Regulates the Wnt/β-catenin Pathway Through the Mir-18A-5p/axin2/gsk3β Axis to Inhibit the Proliferation and Migration of Bladder Cancer Cells.

Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway

LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway

LncRNA LINC00466 Promotes the Progression of Breast Cancer via miR-4731-5p/EPHA2 Pathway

LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression

lncRNA FGD5‐AS1 promotes breast cancer progression by regulating the hsa‐miR‐195‐5p/NUAK2 axis

Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer

LncRNA MAFG-AS1 Affects the Tumorigenesis of Breast Cancer Cells Via the Mir-574-5p/sod2 Axis

Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3

Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway

The Lncrna-Gas5/mir-221-3p/dkk2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer Via the Wnt/β-Catenin Signaling Pathway